GPT‑Rosalind news
The latest GPT‑Rosalind news, : OpenAI acquires Orchestra Bio to boost AI agents for drug development.
2 stories mentioning GPT‑Rosalind since 16 October 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
OpenAI acquires Orchestra Bio to boost AI agents for drug development
OpenAI announced it has acquired Orchestra Bio, a startup that builds AI agents to help pharmaceutical companies manage drug‑development tasks. The company said the acquisition will bring Orchestra’s platform—used for…
4 sourcesTechCrunch AIaxios.comcryptobriefing.comfinance.yahoo.com -
Anthropic reportedly assigned highest junk credit rating in June
Financial news outlets reported that Anthropic received the highest credit rating within the junk category in June, according to ft.com and discussed on Hacker News. The rating could raise the company’s cost of capital…
1 sourcenote.com
Questions about GPT‑Rosalind
What is the latest GPT‑Rosalind news?
As of 20 October 2026: OpenAI acquires Orchestra Bio to boost AI agents for drug development. OpenAI announced it has acquired Orchestra Bio, a startup that builds AI agents to help pharmaceutical companies manage drug‑development tasks.